About PREVENT

PREVENT Cancer Preclinical Drug Development Program

The application cycle is currently closed

The PREVENT program is a peer-reviewed agent development program designed to support preclinical development of innovative interventions and biomarkers for cancer prevention and interception towards clinical trials. PREVENT allocates NCI contract resources and expertise to generate data and materials, which are used by the applicants for further development. PREVENT's current research priority areas include immunoprevention, chemoprevention, and clinically translatable biomarkers. For more information, visit DCP PREVENT.

Create an Account

To apply to the PREVENT program, you must have an account. If you do not have an account, you must register for one; otherwise, you may log in.

Register

Apply to PREVENT

1 Submit an Application

You may submit more than one application per application cycle. All applications must be submitted through this website. Please see application instructions for specifics on creating the concept application which will be uploaded to the application.

NCI will accept only a single resubmission to the PREVENT Program. The resubmission should include responses to the comments and recommendations from the scientific reviews and explain how the application has been modified and strengthened.

Applications are not currently being accepted.

2 Wait for Application Review

Applications are reviewed by the Scientific Review Panel and the Management and Administrative Committee.

  1. The Scientific Review Panel is made of up extramural scientists who are experts in molecular biology, chemoprevention animal efficacy testing, medicinal chemists, immunologists, toxicologists, pharmacologists, drug development, and ad hoc members as needed. This panel reviews, scores, and ranks applications.

  2. The Management and Administrative Committee is made up of Senior Scientists in the DCP staff, Division Leadership, staff from the NCI's Division of Cancer Treatment and Diagnosis, and the Center for Cancer Research.

3 Receive Final Decision

You will be notified of the final decision on applications you have submitted within approximately 4 months.